INTRODUCTION
============

To survive in diverse environments, organisms have developed mechanisms to allow growth under conditions of limiting nutrients. For many organisms including fungi, oxygen is a critical nutrient and cells have evolved ways in which to adapt to a hypoxic environment. Changes in gene transcription and regulation of mRNA translation play a critical role in the response to hypoxia. In mammals, the hypoxia inducible factor (HIF) family of transcription factors are the principal regulators of hypoxic transcription ([@B1]). In addition, hypoxia regulates gene expression by suppressing protein synthesis through the inhibition of translation initiation ([@B2],[@B3]). Both of these mechanisms combine to mediate an adaptive response to limiting oxygen supply in mammalian cells.

In the fission yeast *Schizosaccharomyces pombe*, the transcriptional response to limiting oxygen is mediated by the membrane-bound transcription factor Sre1, the yeast homolog of the mammalian sterol regulatory element binding protein (SREBP) which regulates cellular cholesterol homeostasis ([@B4]). Sre1 (900 aa) contains two transmembrane segments and is inserted into the ER membrane in a hairpin orientation with the N- and C-termini in the cytosol ([@B5]). The N-terminus of Sre1 is a basic helix--loop--helix, leucine zipper transcription factor that binds to a DNA sequence called a Sre1 regulatory element (SRE) to activate transcription of adjacent genes ([@B6]). Under atmospheric oxygen conditions, Sre1 is inactive and remains sequestered in the ER membrane. Under low oxygen, Sre1 exits the ER and is proteolytically cleaved in a post-ER compartment to release the N-terminal transcription factor (Sre1N), which enters the nucleus and activates gene expression. Genome-wide mRNA expression analysis revealed that under low oxygen Sre1 is primarily a transcriptional activator. Sre1 induces expression of 115 genes and controls expression of 68% of genes upregulated \>2-fold under low oxygen ([@B6]). Sre1 target genes include oxygen-dependent enzymes in lipid and heme biosynthesis as well as other gene products expected to be required for hypoxic growth. Consistent with these results, *sre1^+^* is essential for growth under low oxygen conditions ([@B5]). Unlike mammals, regulation of translation by oxygen has not been reported in fission yeast.

To date, Sre1 and SREBPs are believed to function by upregulating protein expression through increased gene transcription ([@B4],[@B7]). In this study, we describe a unique mechanism for oxygen-dependent regulation of translation that requires Sre1. Unexpectedly, Sre1 inhibits protein expression by upregulating transcription of the target gene, *tco1^+^*. Under low oxygen, Sre1 directs transcription of *tco1^+^* from an alternate, upstream promoter that results in a transcript with a longer 5′ untranslated region (UTR). Interestingly, this longer low-oxygen transcript is translationally silent, leading to a decrease in Tco1 protein expression under low oxygen. Collectively, these findings outline a new mechanism for oxygen-dependent control of translation and provide an example of negative regulation of protein expression by an SREBP homolog.

MATERIALS AND METHODS
=====================

Strains, plasmids and standard procedures
-----------------------------------------

*Schizosaccharomyces pombe* wild-type KGY425 (*h*^−^, *his3-D1, leu1-32, ura4-D18, ade6-M210*) and *sre1Δ* strains have been described previously ([@B5],[@B8]). Materials, media and standard procedures including northern blotting, western blotting, chromatin immunoprecipitation and electrophoretic mobility shift assay have been described previously ([@B5],[@B6],[@B9]). Yeast deleted for *tco1^+^*/*SPAC17G6.02c* were generated by homologous recombination using standard techniques by replacing the *tco1^+^* open reading frame with the kanamycin resistance gene ([@B10]). The *tco1^L^*Δ strain was created by replacing −1790 nt to −1250 nt upstream of *tco1^+^* ORF with *ura4^+^*. A *sre1N* plasmid overexpressing *sre1^+^* (1--1320 nt) from the thiamine repressible, nmt promoter was generated by inserting a PCR product into the SalI--BamHI sites of REP3× ([@B11]). The *sre1N* plasmid codes for Sre1(aa 1--440). Supplementary Table 1 contains sequences of oligonucleotides used.

Mapping the ends of *tco1^+^* mRNA
----------------------------------

cDNA was generated using Superscript II (Invitrogen) and an oligo dT primer from DNAse-treated RNA extracted from wild-type cells grown +/− oxygen for 6 h. 5′ and 3′ transcript ends were amplified using Gene Racer kit (Invitrogen). The 5′ and 3′ Rapid Amplification of cDNA Ends (RACE) products were cloned into TOPO-TA vector (Invitrogen) and sequenced. The *tco1^L^* 5′RACE product was sequenced by primer walking in three reactions. Five independent clones were sequenced for both culture conditions and the longest sequence shown by at least two clones was used.

Tco1 antiserum
--------------

An N-terminal GST-fusion to Tco1 (aa 263--324) in pGEX4T1 was expressed in *Escherichia coli* using standard techniques. Recombinant fusion protein was purified using glutathione-agarose beads (Sigma), dialyzed to remove excess glutathione, and used as antigen to generate antiserum (Covance).

Polysome profiling
------------------

Polysomes were isolated as described previously with minor modifications ([@B12],[@B13]). Wild-type cells were grown in rich medium in the presence or absence of oxygen for 8 h, treated with 0.1 mg/ml cycloheximide and immediately placed on ice. Cells were centrifuged, washed in ice-cold lysis buffer (20 mM Tris--HCl pH 8.0, 140 mM KCl, 1.5 mM MgCl~2~, 0.5 mM DTT, 0.1 mg/ml cycloheximide and 1 mg/ml heparin) and lysed with glass beads in 1 ml lysis buffer by vortexing eight times for 30 s with incubation on ice for 30 s between pulses. Following addition of 100 µl each of 10% Triton X-100 and 10% sodium deoxycholate, lysates were incubated on ice for 5 min with an additional vortex pulse of 30 s. Lysates were cleared and 25 A~260nm~ units were layered onto a 11-ml 10--50% (w/v) sucrose gradient (containing 20 mM Tris--HCl pH 8.0, 140 mM KCl, 5 mM MgCl~2~, 0.5 mM DTT, 0.1 mg/ml cycloheximide, 0.5 mg/ml heparin) and centrifuged at 35 000 r.p.m. in a SW41 rotor for 170 min at 4°C. Fractions (∼950 μl) were collected using an ISCO collection system and adjusted to 0.05% SDS. Following addition of yeast tRNA (20 µg/ml) (Invitrogen) and luciferase RNA control (0.1 μg/ml) (Promega) to each fraction, RNA was precipitated overnight and purified using RNeasy mini columns (Qiagen). cDNA was synthesized from RNA using SuperScript First-Strand Synthesis System (Invitrogen). The cDNA was diluted and amplified using gene-specific oligos by quantitative PCR (Bio-Rad) using Sybr-Green (ABgene). The Ct values for the gene of interest were used to determine the normalized value for each fraction using the formula \[2⁁(Ct~luciferase~--Ct~target\ gene~)\]. The relative RNA amount was calculated by dividing the amount in each fraction by the total signal in all fractions.

Model for RNA structure
-----------------------

The predicted secondary structures for *tco1^L^* (−1406 to −1 nt) and *tco1^S^* (−655 to −1 nt) 5′UTR was determined using the GeneBee RNA secondary structure prediction software ([www.genebee.msu.su/services/rna2_full.html](www.genebee.msu.su/services/rna2_full.html)) ([@B14]). Default settings were used to derive the models shown in [Figure 6](#F6){ref-type="fig"}.

RESULTS
=======

Transcriptional profiling experiments of oxygen-dependent gene expression in *S. pombe* identified Sre1 target genes that were upregulated under low oxygen ([@B6]). These target genes functioned in diverse metabolic pathways such as the synthesis of heme, ergosterol, ubiquinone and sphingolipids. Additional expression profiling experiments identified an uncategorized Sre1 target gene *SPAC17G6.02c*, which was upregulated under low oxygen. *SPAC17G6.02c* codes for a 324-aa RTA1-like protein that is predicted to contain seven transmembrane domains. The *Saccharomyces cerevisiae* genome codes for four homologs of *SPAC17G6.02c*: *RSB1, RTA1, RTM1* and an uncharacterized gene *YER185W*. Previous studies demonstrate that these *S. cerevisiae* genes are involved in efflux of different cytotoxic compounds, such as sphingoid long-chain bases by Rsb1p ([@B15]), 7-amino-cholesterol by Rta1p ([@B16]) and an unknown toxic substance in molasses by Rtm1p ([@B17]). Due to the potential function of *SPAC17G6.02c* in oxygen-regulated lipid transport, we characterized this gene further and based on our results we named it *tco1^+^* for translation controlled by oxygen.

To confirm that *tco1^+^* is upregulated under low oxygen by Sre1, we performed northern analysis using a strand-specific probe on RNA isolated from cells grown in the presence or absence of oxygen for increasing time ([Figure 1](#F1){ref-type="fig"}A). To our surprise, while the levels of *tco1^+^* transcript increased under low oxygen, the size of the *tco1^+^* mRNA also increased from ∼2 to ∼3 kb ([Figure 1](#F1){ref-type="fig"}A, lanes 1--4). After 6 h of low oxygen growth, cells expressed the long *tco1^+^* transcript (*tco1^L^*) and not the short *tco1^+^* transcript (*tco1^S^*). Importantly, both the upregulation of *tco1^+^* and the increase in transcript size required Sre1 ([Figure 1](#F1){ref-type="fig"}A, lanes 5--8). Consistent with this, the switch between *tco1^S^* and *tco1^L^* transcripts correlated with the proteolytic activation of Sre1 and the increase of cleaved Sre1N under low oxygen ([Figure 1](#F1){ref-type="fig"}A, lower panel). Figure 1.Low oxygen synthesis of *tco1^L^* requires Sre1. (**A**) Wild-type and *sre1*Δ cells were cultured in the absence of oxygen for increasing time. Upper panel: total RNA (10 µg) was subjected to northern analysis using a *tco1^+^* probe. 25*S* ribosomal RNA was imaged as loading control ([@B29]). Lower panel: cell extracts (40 µg) were analyzed by immunoblotting using antibodies to detect the nuclear form of Sre1 (Sre1N). *tco1^L^* and *tco1^S^* denote the long and short mRNAs for *tco1^+^*, respectively. (**B**) Wild-type cells were grown +/− oxygen for 10 h. Total RNA was harvested and used for 5′ and 3′RACE followed by PCR amplification. Agarose gels resolving the PCR products are shown. The nucleotide lengths of the 5′ and 3′UTRs are given at the right.

The increase in *tco1^+^* transcript length could result from differential splicing or changes in the length of the mRNA UTRs. Given that *tco1^+^* contains no predicted introns, we used RACE to determine the sequences of the 5′ and 3′UTRs for each transcript. In the presence of oxygen, the *tco1^S^* 5′UTR was 655 nt and in the absence of oxygen the *tco1^L^* 5′UTR was 1406 nt ([Figure 1](#F1){ref-type="fig"}B, top panel). The 3′RACE revealed that the 3′UTR was 390 nt in both the *tco1^L^* and *tco1^S^* transcripts ([Figure 1](#F1){ref-type="fig"}B, bottom panel). In addition, the coding sequences of *tco1^L^* and *tco1^S^* were the same length as determined by RT--PCR. These data indicate that *tco1^L^* and *tco1^S^* differ in size due to the presence of an additional 751 nt in the 5′UTR of *tco1^L^*.

Thus far, the data are consistent with a model in which under low oxygen Sre1 directs transcription of *tco1^L^* from an anaerobic promoter upstream of the aerobic promoter that produces *tco1^S^*. To test whether Sre1 binds to the *tco1^+^* promoter *in vivo* under low oxygen, we performed a chromatin immunoprecipitation experiment. Using primers positioned 100-bp upstream of the start of the *tco1^L^* transcript to detect DNA binding, Sre1 bound specifically to the *tco1^+^* promoter and binding was increased 5-fold under low oxygen ([Figure 2](#F2){ref-type="fig"}A). Sre1 displayed oxygen-dependent binding to the promoter of *hem13^+^*, a gene required for heme biosynthesis, but not the Tf2-11 retrotransposon as expected from previous results ([@B6],[@B9]). Next, we scanned the genomic sequence 500-bp upstream of the *tco1^L^* 5′UTR for sequences that matched the SRE consensus sequence determined previously ([@B6]). Two potential SREs were identified ([Figure 2](#F2){ref-type="fig"}B, Probes A and B) and we assayed these sequences for their ability to bind the DNA-binding domain of Sre1 *in vitro* in an electrophoretic mobility shift assay ([Figure 2](#F2){ref-type="fig"}B). Sre1 bound to Probe A located −1527 to −1518 nt upstream of the *tco1^+^* ORF as well as the positive control Probe C, a SRE from the promoter of *sre1^+^* ([Figure 2](#F2){ref-type="fig"}B, lanes 2 and 4) ([@B6]). Sre1 did not bind the other candidate SRE, Probe B located at −1651 to −1642 nt ([Figure 2](#F2){ref-type="fig"}B, lane 3). Together, these *in vitro* and *in vivo* binding experiments suggest that under anaerobic conditions, Sre1N binds to a SRE upstream of *tco1^+^*, leading to the synthesis of *tco1^L^*. Figure 2.Sre1 binds to the *tco1^+^* promoter. (**A**) Wild-type yeast were grown +/− oxygen for 6 h and subjected to chromatin immunoprecipitation using anti-Sre1 IgG or rabbit IgG. Bound DNA was normalized to wild-type + oxygen for each primer pair. The DNA bound values for the immunoprecipitation with anti-Sre1 under aerobic conditions were 0.005 (*tco1^+^)*, 0.012 (*hem13^+^)* and 0.0012 (Tf2--11). Error bars denote one standard deviation among three experimental replicates. (**B**) Sre1 DNA-binding domain (aa 256--366) was incubated with indicated ^32^P-labeled DNA probes and subjected to electrophoretic mobility shift assay. Probes A and B represent sequences upstream of *tco1^+^* ORF, −1527 to −1518 nt and −1651 to −1642 nt, respectively. Probe C is the Sre1 binding sequence from the *sre1^+^* promoter and has been described previously ([@B6]). (**C**) Wild-type and *tco1^L^*Δ cells were cultured +/− oxygen for 10 h. Upper panel: total RNA (10 µg) was subjected to northern analysis using a *tco1^+^* probe. 25*S* ribosomal RNA was imaged as loading control.

The low oxygen increase in *tco1^L^* transcript is accompanied by a decrease in *tco1^S^* transcript. To investigate if synthesis of *tco1^L^* is required for decreased levels of *tco1^S^*, we deleted sequences upstream of *tco1^S^* predicted to contain the transcriptional start site and regulatory elements for *tco1^L^*. In this strain designated *tco1^L^Δ*, *tco1^L^* transcript was not expressed under low oxygen and *tco1^S^* transcript was still present after 10 h of growth under low oxygen ([Figure 2](#F2){ref-type="fig"}C). These results indicate that *tco1^L^* transcription is required to inhibit *tco1^S^* synthesis and that Sre1 does not directly block *tco1^S^* expression.

Sequence analysis predicted that both the *tco1^L^* and *tco1^S^* transcripts code for the same protein. To examine the translation products of these two transcripts, we raised antibodies to the C-terminus of Tco1, which is a predicted membrane protein. Microsomes were prepared from wild-type, *sre1*Δ and *tco1*Δ cells grown in presence or absence of oxygen for 6 h and these membranes were analyzed by immunoblotting for Tco1 ([Figure 3](#F3){ref-type="fig"}A, upper panels). Antibodies specifically recognized Tco1 as a doublet migrating ∼30 kDa ([Figure 3](#F3){ref-type="fig"}A, compare lanes 1 and 5). Interestingly, when wild-type cells were cultured under low oxygen to induce the *tco1^L^* transcript, levels of Tco1 protein were dramatically reduced ([Figure 3](#F3){ref-type="fig"}A, lanes 1 and 2). In contrast, no decrease in Tco1 was observed under low oxygen in *sre1*Δ cells which expressed *tco1^S^* ([Figure 3](#F3){ref-type="fig"}A, lanes 3 and 4). As expected, Sre1N levels were highly upregulated under low oxygen in wild-type and *tco1*Δ cells ([Figure 3](#F3){ref-type="fig"}A, lower panel). These results indicate that under low oxygen Tco1 protein expression is inhibited by a mechanism that requires Sre1. Figure 3.Sre1 inhibits Tco1 protein expression. (**A**) Wild-type, *sre1*Δ, and *tco1*Δ cells were cultured for 6 h +/− oxygen. Upper panels: membrane protein samples (40 µg) were analyzed using antibodies raised against the C-terminus of Tco1 or cell lysates (40 µg) were analyzed by immunoblotting for nuclear Sre1. Lower panels: total RNA (10 µg) was subjected to northern analysis using a *tco1^+^* probe. 25*S* rRNA was imaged as loading control. *tco1^L^* and *tco1^S^* denote the long and short mRNAs for *tco1^+^*, respectively. (**B**) Wild-type cells expressing *sre1N* from a plasmid under control of the thiamine repressible, nmt promoter were cultured in minimal medium in the presence (repressed) or absence (induced) of thiamine (5 µg/ml) for 24 h. Cells were diluted, cultured under the same conditions for 24 h and harvested in exponential phase. Upper panels: membrane proteins (36 µg) and cell lysates (40 µg) were immunoblotted using anti-Tco1 and anti-Sre1, respectively. Lower panels: total RNA (10 µg) was subjected to northern analysis using a *tco1^+^* probe. 25*S* rRNA was imaged as loading control. *tco1^L^* and *tco1^S^* denote the long and short mRNAs for *tco1^+^*, respectively.

To test whether inhibition of Tco1 synthesis requires both activation of Sre1 and low oxygen, we overexpressed Sre1N in the presence of oxygen in wild-type cells. Cells carrying either empty vector or a plasmid expressing Sre1N from a thiamine repressible promoter were grown in the presence or absence of thiamine ([@B18]). Overexpression of Sre1N induced *tco1^L^* and inhibited expression of Tco1 even in the presence of oxygen ([Figure 3](#F3){ref-type="fig"}B, lanes 3 and 4). Cells carrying the empty vector synthesized *tco1^S^* and showed aerobic levels of Tco1 ([Figure 3](#F3){ref-type="fig"}B, lanes 1 and 2). These data indicate that activation of Sre1 is sufficient to induce expression of *tco1^L^* and inhibit Tco1 expression.

Next, we tested whether the inhibition of Tco1 expression by Sre1 is reversible. Sre1N has a short half-life of 5--10 min, and cleavage of Sre1 is rapidly inhibited upon shifting cells to the presence of oxygen (B.H. and P.E., unpublished data). Thus, Sre1N levels decrease rapidly after reintroducing oxygen to an anaerobic culture. For this experiment, we grew wild-type cells in the absence of oxygen for 10 h to induce *tco1^L^* and inhibit Tco1 expression ([Figure 4](#F4){ref-type="fig"}, lane 2). Cells were then harvested at different times following a shift to aerobic conditions. As expected, Sre1N and *tco1^L^* accumulated under low oxygen ([Figure 4](#F4){ref-type="fig"}, lanes 1 and 2). After shifting to aerobic conditions for 30 min, Sre1N disappeared and there was a corresponding switch from the *tco1^L^* to the *tco1^S^* transcript. Tco1 protein was detectable at 30 min and continued to increase to 120 min ([Figure 4](#F4){ref-type="fig"}, lanes 2--5). These data indicate that the Sre1-dependent inhibition of Tco1 expression is reversible and provide further evidence that expression of the *tco1^L^* transcript leads to decreased Tco1 protein. In addition, these results suggest that the *tco1^L^* transcript has a short half-life since it disappeared 30 min after inhibiting Sre1 proteolytic activation. Figure 4.Low oxygen inhibition of Tco1 expression is reversible. Wild-type cells were grown in the presence of oxygen (lane 1) or in the absence of oxygen for 10 h and then shifted to aerobic conditions for the indicated times (lanes 2--5). Upper panels: membrane proteins (40 µg) and cell lysates (40 µg) were immunoblotted using anti-Tco1 and anti-Sre1, respectively. Lower panels: total RNA (10 µg) was subjected to northern analysis using a *tco1^+^* probe. 25*S* rRNA was imaged as loading control. *tco1^L^* and *tco1^S^* denote the long and short mRNAs for *tco1^+^*, respectively.

This oxygen-dependent regulation of Tco1 by Sre1 could result from the differential translation of *tco1^S^* and *tco1^L^* transcripts. To investigate this directly, we performed a polysome profiling experiment. Wild-type yeast were grown in the presence or absence of oxygen for 8 h to generate cells expressing either the *tco1^S^* or *tco1^L^* transcript, respectively. Cell lysates were fractionated on a sucrose gradient to separate ribosome-associated RNA from free RNA. Overall, there was no significant difference in the two polysome profiles, suggesting that translation efficiency was similar in the presence and absence of oxygen for 8 h ([Figure 5](#F5){ref-type="fig"}A). To examine the translation status of *tco1^+^* mRNAs, we isolated RNA from each fraction and quantified individual mRNAs by RT--PCR. First, we used oligos to the coding region of *tco1^+^* to monitor the association of *tco1^+^* mRNA with ribosomes ([Figure 5](#F5){ref-type="fig"}B, left panel). In the presence of oxygen, *tco1^S^* mRNA associated with polysomes in Fractions 6--12 ([Figure 5](#F5){ref-type="fig"}B, left, solid line). In the absence of oxygen, *tco1^L^* mRNA cofractionated with unassembled ribosomal subunits in Fractions 2--4 ([Figure 5](#F5){ref-type="fig"}B, left, dotted line). In contrast, the *sre1^+^* transcript fractionated with polysomes in both the presence and absence of oxygen, indicating that the gradient fractionation and mRNA isolation were identical under the two conditions ([Figure 5](#F5){ref-type="fig"}B, right panel). Figure 5.*tco1^L^* transcript fails to associate with ribosomes. (**A**) Polysome profiles of wild-type cells cultured +/− oxygen for 8 h. Cell lysates were fractionated on a sucrose density gradient and absorbance at 260 nm was continuously measured for each fraction to detect RNA. Positions of the 40*S* and 60*S* ribosomal subunits, 80*S* monosomes and polysomes are indicated. (**B**) The amount of individual RNAs in each fraction was determined by real-time RT--PCR and the percentage of total RNA on the gradient is plotted for each fraction. The *tco1^+^* (left panel) and *sre1^+^* (right panel) transcripts were quantified using oligos in the *tco1^+^* and *sre1^+^* ORFs. The solid line denotes + oxygen sample and the dotted line denotes --oxygen sample. (**C**) The absolute amount of *tco1^L^* in each fraction is plotted after normalization with the extraction standard. The solid line denotes + oxygen sample and the dotted line denotes --oxygen sample.

To examine the association of *tco1^L^* mRNA with ribosomes directly, we detected this transcript using primers directed to its unique 5′UTR. As expected, cells grown in the absence of oxygen had elevated levels of *tco1^L^* compared to cells grown in the presence of oxygen ([Figure 5](#F5){ref-type="fig"}C). In the absence of oxygen, *tco1^L^* fractionated with unassembled ribosomal subunits ([Figure 5](#F5){ref-type="fig"}C, dotted line). To test whether the failure of *tco1^L^* to associate with ribosomes was dependent on the absence of oxygen, we determined the translation status of the small amount of *tco1^L^* mRNA that is synthesized in the presence of oxygen ([Figure 5](#F5){ref-type="fig"}C, solid line). Even in the presence of oxygen, *tco1^L^* fractionated at the top of the gradient in Fractions 2 and 3. Collectively, these data indicate that *tco1^S^* is primarily associated with polysomes and therefore efficiently translated, while *tco1^L^* fails to associate with ribosomes and is poorly translated. In addition, this property of *tco1^L^* is independent of oxygen and thus likely results from sequence differences between the two mRNA transcripts.

RNA secondary structure can affect translation efficiency ([@B19]). In particular, stable stem-and-loop structures in the 5′UTR can inhibit translation initiation ([@B20]). To investigate whether the structure of the *tco1^+^* mRNAs could contribute to their differential association with ribosomes, we used RNA structure programs to predict the secondary structure of the *tco1^L^* and *tco1^S^* 5′UTRs. Two different RNA structure programs (M-fold and GeneBee) predicted that the *tco1^L^* 5′UTR folds to form a highly structured, stable RNA ([Figure 6](#F6){ref-type="fig"}). In contrast, the *tco1^S^* 5′UTR was predicted to contain less secondary structure with a higher Gibbs energy of formation. The models predicted by GeneBee are shown in [Figure 6](#F6){ref-type="fig"}. These data suggest that the *tco1^L^* 5′UTR may assume a complex secondary structure that prevents efficient translation of the *tco1^+^* ORF. Figure 6.Predicted secondary structures for the 5′UTRs of *tco1^L^* and *tco1^S^*. The secondary structure for the 5′UTR sequence of the anaerobic *tco1^L^* (**A**) and aerobic *tco1^S^* (**B**) transcripts, as predicted by the GeneBee RNA secondary structure prediction software ([www.genebee.msu.su/services/rna2_full.html](www.genebee.msu.su/services/rna2_full.html)) ([@B14]). The Gibbs energy of formation for each folded RNA is shown. Nucleotide positions are given relative to the Tco1 AUG initiation codon.

DISCUSSION
==========

In this study, we describe a unique mechanism for translational control by oxygen via the low oxygen transcription factor Sre1. Genome-wide expression analysis identified *tco1^+^* as a Sre1 target gene of unknown function. Here, our characterization revealed that *tco1^+^* mRNA is upregulated under low oxygen by Sre1 ([Figure 1](#F1){ref-type="fig"}A). Counterintuitively, this increased gene expression leads to decreased Tco1 protein due to the Sre1-dependent synthesis of a poorly translated, alternative transcript, *tco1^L^*. Our data are summarized by a model for regulation of *tco1^+^* expression outlined in [Figure 7](#F7){ref-type="fig"}. In the presence of oxygen, Sre1 is inactive and cells synthesize a 2020-nt mRNA *tco1^S^* that is efficiently translated into Tco1 protein. In the absence of oxygen, Sre1 is proteolytically activated leading to an increase in Sre1N which binds to the *tco1^+^* promoter and directs expression of the 2771-nt mRNA *tco1^L^* from an alternative, upstream promoter. At the same time, expression of *tco1^S^* is blocked. The *tco1^L^* transcript associates inefficiently with ribosomes, leading to an inhibition of Tco1 protein expression. Figure 7.Model for regulation of Tco1 expression by oxygen. In presence of oxygen, the *tco1^S^* transcript is synthesized and translated into Tco1 protein. Synthesis of *tco1^S^* does not require Sre1. In the absence of oxygen, Sre1 is activated and binds to a SRE present upstream of *tco1^+^*, initiating transcription of *tco1^L^* from an alternative promoter. The 5′UTR of the *tco1^L^* transcript forms a secondary structure that prevents association with ribosomes. The nucleotide length of each transcript is given.

Polysome profiling experiments demonstrated that *tco1^S^*, but not *tco1^L^*, is efficiently translated ([Figure 5](#F5){ref-type="fig"}). These two transcripts differ only in the length of their 5′UTRs. The 5′UTR of *tco1^L^* contains an additional 751 nt and is predicted to assume a more complex and stable secondary structure than the *tco1^S^* 5′UTR ([Figure 6](#F6){ref-type="fig"}). Inasmuch as RNA secondary structure is known to affect translation initiation and efficiency, the structure of *tco1^L^* 5′UTR could directly inhibit Tco1 translation ([@B19; @B20; @B21]). Alternatively, the *tco1^L^* 5′UTR contains 14 AUG initiation codons compared to three in *tco1^S^*. The 5′UTRs of *tco1^L^* and *tco1^S^* code for seven ORFs (ranging from 3 to 97 aa in length) and three ORFs (8 --19 aa in length), respectively. Upstream ORFs (uORFs) can regulate translation of downstream ORFs by preventing reinitiation of ribosomes after translation termination ([@B22]). In this way, uORFs present in the *tco1^L^* 5′UTR could prevent translation of Tco1. Consistent with this possibility, 35--40% of *tco1^L^* mRNA was found to be associated with polysomes in fractions 6--12 ([Figure 5](#F5){ref-type="fig"}B). Examples exist in *S. cerevisiae* and humans in which transcription from an alternative promoter leads to a different 5′UTR and less efficient translation, but the mechanisms involved in this regulation are unknown ([@B23],[@B24]). Future experiments will determine the functional contribution of these two mechanisms to the inhibition of Tco1 translation.

One question that arises from these observations is why do cells make the *tco1^L^* transcript if it is not translated? One possible explanation is that inhibition of *tco1^S^* synthesis requires active transcription from the upstream *tco1^L^* promoter through a mechanism such as transcriptional interference or promoter competition ([@B25],[@B26]). The regulated transcription of *SER3* in *S. cerevisiae* is a well-characterized example of transcriptional interference in which the upstream, noncoding *SRG1* transcript inhibits transcription from the *SER3* promoter ([@B27]). In addition, the alcohol dehydrogenase gene in *Drosophila melanogaster* is regulated by two closely linked promoters during larval development. During late larval stages, there is a switch in promoter usage, wherein the distal promoter represses transcription from the proximal promoter by transcriptional interference ([@B28]). Here, transcription from the *tco1^L^* promoter inhibits transcription of *tco1^S^* ([Figure 2](#F2){ref-type="fig"}C), but both transcripts code for the same protein product. In an alternative model, active transcription from the *tco1^L^* promoter could maintain an open chromatin state in order to allow rapid synthesis of *tco1^S^* and Tco1 upon the reintroduction of oxygen and loss of Sre1N. A similar idea has been proposed to explain the production of translationally silent transcripts in response to mating pheromone in *S. cerevisiae* ([@B23]).

Finally, while our experiments do not directly address the physiological function of Tco1, we find that expression of Tco1 decreases under low oxygen due to a block in translation. *tco1^+^* is a nonessential gene and we have failed to detect any phenotypes associated with the loss or overexpression of Tco1 under anaerobic or other standard laboratory conditions. By homology to the characterized *S. cerevisiae* transporters Rta1p, Rsb1p and Rtm1p, we speculate that Tco1 may export a toxic compound(s) from cells under aerobic conditions, but that this substrate is either absent or no longer toxic under anaerobic conditions. Future experiments will address the physiological basis for this unique mechanism for inhibition of Tco1 translation under low oxygen.
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